- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GILD
Recent news which mentions GILD
7 Cash-Rich Companies to Invest in During Economic Uncertainty
February 26, 2023
From InvestorPlace
3 Stocks to Buy Right Now That Are Cash Cows
February 25, 2023
From Motley Fool
WHO panel is reviewing whether COVID vaccines need updating, as agency monitors 7 omicron subvariants
February 24, 2023
From MarketWatch
GSK/Pfizer-Backed ViiV Healthcare's HIV Treatment At Par With Gilead's: Study Shows
February 23, 2023
From Benzinga
This Recession-Proof Company Has a Best-in-Class Dividend
February 22, 2023
From Motley Fool
Lattice Semiconductor To Rally 33%? Here Are 10 Other Analyst Forecasts For Tuesday
February 14, 2023
From Benzinga
From InvestorPlace
Kite's Tecartus CAR T-Cell Therapy Demonstrates Durable Overall Survival Benefit In Leukemia Settings
February 09, 2023
Tickers
GILD
From Benzinga
2 Biotech Stocks That Could Make You Richer
February 09, 2023
From Motley Fool
Is Gilead Sciences a Good Stock to Buy Now?
February 06, 2023
From Motley Fool
Gilead Sciences' Trovelvy Scores FDA Approval For Advanced/Metastatic Breast Cancer Setting
February 03, 2023
Tickers
GILD
From Benzinga
'Risk Of Overheating': 4 Experts On Hot January Jobs Report, How The Fed Will React
February 03, 2023
From Benzinga
Nasdaq Futures Deflate As Apple Leads Tech Disappointments: Traders Look To Jobs Data For Mitigating Impact
February 03, 2023
From Benzinga
Tickers
GILD
From Motley Fool
Gilead Sciences (GILD) Q4 2022 Earnings Call Transcript
February 02, 2023
Tickers
GILD
From Motley Fool
Why Gilead Sciences Stock Is Trading Higher After Hours
February 02, 2023
Tickers
GILD
From Benzinga
This trader nailed two big market calls in 2022. She says investors are ‘being paid to wait’ so should steer clear of stocks for 2023.
February 02, 2023
From MarketWatch
Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?
February 02, 2023
From Benzinga
From Benzinga
These 3 Healthcare Stocks With Over 3% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts
January 31, 2023
From Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
January 29, 2023
From Benzinga
Could Gilead Sciences Stock Help You Become a Millionaire?
January 26, 2023
Tickers
GILD
From Motley Fool
3 Smart Stocks to Buy if a Recession Is on the Way
January 21, 2023
From Motley Fool
3 Stocks That Beat the S&P During the Great Recession
January 18, 2023
From Motley Fool
2 Unstoppable Stocks That Could Beat the Market Again In 2023
January 11, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.